Company intelligence / Profile preview

Novioscan

Nijmegen, Netherlands

Ownership: Private
Development stage: Other

Overview

Novioscan has commercialized the SENS-U bladder sensor, a CE-marked Class IIA medical device since March 2018. The device is clinically validated in collaboration with UMC Utrecht, with results published in the Journal of Pediatric Urology. It is currently being used by urologists and pediatricians in numerous Dutch hospitals[3][5].

Therapeutic areas: Nephrology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

University Medical Center (UMC) Utrecht[3][5]

Beyond the preview

Go deeper on Novioscan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novioscan.

Explore the full profile